Monday 22 May 2023 See also: Hugues de Thé Documents and media Download program pdf (380.33 KB) Program Symposium 09:15 - 09:30 Introduction Hugues de Thé 22 May 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 May 2023 09:15 - 09:30 Symposium 09:30 - 10:00 New Approaches to Cancer Therapy Rene Bernards 22 May 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 May 2023 09:30 - 10:00 Symposium 10:00 - 10:30 Precision Oncology with DNA Targeted Agents and the NCI PatientMiner Web Application Yves Pommier 22 May 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 May 2023 10:00 - 10:30 Symposium 10:30 - 10:50 Harnessing Genetic Vulnerabilities in Immuno-Oncology: Novel Therapeutic Opportunities Sophie Postel-Vinay 22 May 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 May 2023 10:30 - 10:50 Symposium 11:20 - 11:50 Killing Cancer by DNA Damage Through Synthetic Lethality Thomas Helleday 22 May 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 May 2023 11:20 - 11:50 Symposium 14:00 - 14:30 Metabolic Bases of Responses to Chemotherapy in Leukemia Jean-Emmanuel Sarry 22 May 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 May 2023 14:00 - 14:30 Symposium 14:30 - 15:00 SUMOylation Controls Acute Myeloid Leukemias Response to (Chemo)therapies Guillaume Bossis 22 May 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 May 2023 14:30 - 15:00 Symposium 15:20 - 15:50 Not recorded Microbially Derived Adjuvants for Cancer Chemotherapy Filipe Cabreiro 22 May 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 May 2023 15:20 - 15:50 Symposium 15:50 - 16:20 Revisiting Chemotherapy Failure-From a Senescence Point-of-view Clemens Schmitt 22 May 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 May 2023 15:50 - 16:20 Symposium 16:20 - 17:00 Conclusions Hugues de Thé 22 May 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 May 2023 16:20 - 17:00 See also Hugues de Thé, chair Cellular and Molecular Oncology
Symposium 09:15 - 09:30 Introduction Hugues de Thé 22 May 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 May 2023 09:15 - 09:30
Symposium 09:30 - 10:00 New Approaches to Cancer Therapy Rene Bernards 22 May 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 May 2023 09:30 - 10:00
Symposium 10:00 - 10:30 Precision Oncology with DNA Targeted Agents and the NCI PatientMiner Web Application Yves Pommier 22 May 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 May 2023 10:00 - 10:30
Symposium 10:30 - 10:50 Harnessing Genetic Vulnerabilities in Immuno-Oncology: Novel Therapeutic Opportunities Sophie Postel-Vinay 22 May 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 May 2023 10:30 - 10:50
Symposium 11:20 - 11:50 Killing Cancer by DNA Damage Through Synthetic Lethality Thomas Helleday 22 May 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 May 2023 11:20 - 11:50
Symposium 14:00 - 14:30 Metabolic Bases of Responses to Chemotherapy in Leukemia Jean-Emmanuel Sarry 22 May 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 May 2023 14:00 - 14:30
Symposium 14:30 - 15:00 SUMOylation Controls Acute Myeloid Leukemias Response to (Chemo)therapies Guillaume Bossis 22 May 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 May 2023 14:30 - 15:00
Symposium 15:20 - 15:50 Not recorded Microbially Derived Adjuvants for Cancer Chemotherapy Filipe Cabreiro 22 May 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 May 2023 15:20 - 15:50
Symposium 15:50 - 16:20 Revisiting Chemotherapy Failure-From a Senescence Point-of-view Clemens Schmitt 22 May 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 May 2023 15:50 - 16:20
Symposium 16:20 - 17:00 Conclusions Hugues de Thé 22 May 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 May 2023 16:20 - 17:00
